CLINICAL ROLE -
Trending News Today: New Medicaid Managed Care Program Moves Away From Fee-for-Service Billing
Top news of the day from across the health care landscape.
Read More
Study to Evaluate HIV, Zika Coinfection in Pregnant Women
Investigators aim to determine whether Zika virus interferes with antiretroviral drugs that prevent mother-to-child transmission of HIV.
Health Care System Falls Short for the Aging HIV-Positive Latino Population
Report finds socioeconomic factors that increase vulnerability to HIV.
Guselkumab Granted FDA Approval for Plaque Psoriasis
Tremfya is the first and only approved biologic that selectively blocks the interleukin-23 protein.
FDA Approves Biologic Plaque Psoriasis Drug
Tremfya found to achieve significantly clearer skin in moderate to severe plaque psoriasis.
Is a Novel Non-Surgical Circumcision Device a Viable Option for HIV Prevention?
Voluntary medical male circumcision may help to reduce the spread of HIV.
Trending News Today: Silicon Valley Firm, Abbott Lab Join Forces to Improve Glucose Monitoring for Diabetes
Hemophilia A Drug Reduces Number of Bleeding Episodes by Nearly 90%
Emicizumab is administered subcutaneously only once per week compared with clotting factors administered intravenously 3 times per week.
Phase 2 Study to Examine Novel Combination Hepatitis B Treatment
Selective oral immunomodulator plus tenofovir alafenamide (Vemlidy) seeks functional cure in chronic HBV.
FDA Committee Votes in Favor of B-Cell Acute Lymphoblastic Leukemia Drug
CTL019 is a chimeric antigen receptor T cell therapy.
Trending News Today: Fifth Confirmed Death in California Caused by Hepatitis A Outbreak
European Medicines Agency Validates Single Tablet Regimen Filing for HIV
The once-daily drug contains bictegravir and emtricitabine/tenofovir to treat adults with HIV-1.
Biosimilar Uptake Challenges: Low-Cost Specialty Drugs Reduce Provider Profits
Study finds the current reimbursement model for biosimilars needs to be adjusted to improve uptake.
Added Benefit of Antiviral Drug Unproven in Treatment of Chronic Hepatitis B Virus
No data were presented for treatment-naïve and pretreated adolescents with hepatitis B virus.
Oral Drug Demonstrates Favorable Benefit-Risk Profile in Non-Hodgkin Lymphoma
Investigators believe oral duvelisib may represent an important new treatment option for lymphoma patients.
Investors May Be Losing Faith in Manufacturer as HIV Marketplace Changes
Competition in HIV drug development affecting stock market.
Ancient Retrovirus Uses 2 Mechanisms to Interfere with HIV Replication
Inhibiting particle release and infectivity could lead to a cure for HIV-1.
Trending News Today: Syphilis Cases on the Rise, Attributed to Social Media
New Clinical Trial Data Shows HIV Drugs in the Pipeline
Merck will present late-breaker abstracts at upcoming IAS 2017 conference.
Comorbid Conditions Delay Colorectal Cancer Diagnosis
Cancer diagnoses delayed by an average of 9 days in patients with preexisting conditions.
Lipoic Acid Slows Brain Deterioration in Secondary Progressive Multiple Sclerosis
Over-the-counter therapy could improve overall wellbeing in patients with multiple sclerosis.
Investigational Antiretroviral Ibalizumab Granted Priority Review
The Biologics License Application for ibalizumab is under review for the treatment of multidrug resistant HIV-1.
Continued Use of Certolizumab Pegol Safe in Pregnant Women with Rheumatoid Arthritis, Study Suggests
Findings confirm no or negligible placental transfer of anti-TNF drug in women with rheumatoid arthritis.
Text Messages Improve Patient Care in Treatment of HIV, Tuberculosis
Messaging based on patient medical records allow for more personalized care in HIV and other conditions.
Trending News Today: Are Coffee Drinkers Living Longer?
Prostate Drug Linked to Diabetes, Worsening Erectile Dysfunction
Dutasteride (Avodart) increases blood sugar, A1C, and blood lipids.
Trial Data Further Supports Xeljanz Plus Methotrexate Combination in Rheumatoid Arthritis
The trial is the first to compare Xeljanz alone or in combination with MTX versus adalimumab plus MTX.
Second Loss for AbbVie in Humira Patent Case
Boehringer Ingelheim seeks to launch its biosimilar to Humira.
Health Officials Investigate Hepatitis A Virus Outbreak
Reports confirm 10 hepatitis A-related deaths in Detroit area over the past year.
FDA Flags 3 Keytruda Combination Trials in Multiple Myeloma
Two KEYNOTE trials were placed on full clinical hold and 1 partial clinical hold.